SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Sep-24 7:10 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 27-Sep-24 | Market Purchase | 21,400 | $23.33 | $499,262.00 | 100% 0 to 21.4K | (1%) |
02-Dec-22 4:23 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 30-Nov-22 | Grant | 3,000 | $0.94 | $2,820.00 | 21% 14.26K to 17.26K | |
20-Sep-21 5:02 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 16-Sep-21 | Market Sale | 5,736 | $6.73 | $38,603.30 | (29%) 20.0K to 14.26K | (16%) |
16-Sep-21 7:41 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 14-Sep-21 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
29-May-18 7:18 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 29-May-18 | Conversion | 6,392 | -- | -- | 6% 109.8K to 116.19K |